Posted On November 3, 2026 /
By Debbie Muse / Posted in Blog
Dr. Abbey Reports on Latest Study Evaluating DME Outcomes After Switching from Faricimab-svoa to High-dose Aflibercept
In the latest issue of Ophthalmic Surgery, Lasers & Imaging Retina, Texas Retina’s Ashkan M. Abbey, MD, co-authored a retrospective study evaluating the effectiveness of high-dose aflibercept 8 mg (Eylea HD) in
read more